Emricasan
- Generic Name
- Emricasan
- Drug Type
- Small Molecule
- Chemical Formula
- C26H27F4N3O7
- CAS Number
- 254750-02-2
- Unique Ingredient Identifier
- P0GMS9N47Q
Overview
Emricasan is the first caspase inhibitor tested in human which has received orphan drug status by FDA. It is developed by Pfizer and made in such a way that it protects liver cells from excessive apoptosis.
Background
Emricasan is the first caspase inhibitor tested in human which has received orphan drug status by FDA. It is developed by Pfizer and made in such a way that it protects liver cells from excessive apoptosis.
Indication
Investigated for use/treatment in hepatitis (viral, C), liver disease, and transplantation (organ or tissue).
Associated Conditions
No associated conditions information available.
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath